News and Events

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

BVCA – Healthcare Forum

Sphere Fluidics is a finalist in the Medicine Maker Innovation Awards and now needs a public vote.

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

University of Manchester and Sphere Fluidics publish a review on single cell analysis by mass spectrometry in the scientific journal "Analyst".

The Scientist names Cyto-Mine® technology #1 in the Top 10 Innovations of 2018.

Read about 'The Future of Antibody Discovery and Cell Line Development'

Sphere Fluidics are Exhibiting